Nutritional Screening in IBD: 3 out of 4 Patients Have Never Been Assessed, and Nearly 1 in 4 Are at High Risk for Malnutrition | AMICI National Survey of 3,848 Patients

LOW RATE OF NUTRITIONAL SCREENING DESPITE HIGH PREVALENCE OF RISK FOR MALNUTRITION IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF AN ITALIAN PATIENT SURVEY

27th ADI National Congress, Matera, October 8–10, 2026

The national survey, sponsored by AMICI Italia in collaboration with LIONHEALTH, estimates the prevalence of malnutrition risk in people with Malnutrition (IBD) using the Universal Screening Tool (MUST) and assesses how frequently nutritional screening is performed in real-world clinical practice. The 2023 ESPEN guidelines on clinical nutrition in IBD recommend screening for malnutrition at diagnosis and, subsequently, at regular intervals (Recommendation 4, grade GPP, 100% consensus).

A total of 3,848 patients responded (Crohn’s disease 41.6%, ulcerative colitis 48.2%, indeterminate colitis 3.2%, none/other 7%). 75.4% had never undergone a nutritional risk assessment by a healthcare professional. According to the MUST, 57.9% of respondents were classified as low risk, 17.4% as moderate risk, and 24.7% as high risk. A BMI below 18.5 was reported by 10.8% of respondents, and an additional 19.3% reported a BMI between 18.5 and 20; 13.6% reported weight loss of more than 5%, and 12.3% reported an acute illness or insufficient food intake for more than 5 days.

Nearly one in four respondents (about 25%) meets the MUST criteria for high nutritional risk, while three out of four (about 75%) have never been assessed: a substantial gap between guidelines and actual clinical practice. Systematic nutritional screening should become a standard component of IBD care pathways, using validated tools such as the MUST in routine follow-up and predefined referral pathways to dietitians or clinical nutrition specialists for at-risk patients. Patient organizations can also help identify unmet needs and support the implementation of screening in daily practice. Authors (initials + last name in bold):

S. Leone, AMICI Italia, Milan; V. Pagella, Lionhealth Società Benefit, Milan; E. Previtali, AMICI Italia, Milan; C. Fiorindi, Careggi University Hospital, Florence; E.P. Lanati, Lionhealth Società Benefit, Milan

Accepted and presented at:

  • 27th ADI National Congress, Matera, October 8–10, 2026 (abstract, oral presentation)
  • 9th SINuC National Congress, Parma, October 19–21, 2026 (poster), to be published online in *Frontiers in Clinical Nutrition*

 

 

small gestures count
small gestures count

small gestures count

This screen saves power when you step away from the pc


clicking anywhere on the screen will return you to the page you were visiting

Blue LH Jar

LH BLU: New “ FSMPs ” for the treatment of malnutrition in cancer patients, including those with mucositis